SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001618835-20-000036
Filing Date
2020-02-26
Accepted
2020-02-26 20:15:48
Documents
4
Period of Report
2020-02-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_158276613035403.html 3  
1 FORM 3 wf-form3_158276613035403.xml 3 1773
2 RARICK POA evogensection16powerofat.htm EX-24 4534
3 GRAPHIC 1 evogensection16powerofat001.jpg GRAPHIC 203002
4 GRAPHIC 2 evogensection16powerofat002.jpg GRAPHIC 37590
  Complete submission text file 0001618835-20-000036.txt   339385
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Issuer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EVOFEM BIOSCIENCES, INC. 12400 HIGH BLUFF DRIVE, STE 600 SAN DIEGO CA 92130
Business Address
Rarick Lisa Dale (Reporting) CIK: 0001803550 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36754 | Film No.: 20657985